{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:10:08Z","timestamp":1778130608011,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MedScience"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11684-025-1199-2","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:35:26Z","timestamp":1771032926000},"page":"186-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diffuse large B-cell lymphoma combined with hyperlactatemia presents high mortality: case report and literature review"],"prefix":"10.1007","volume":"20","author":[{"given":"Yu","family":"Jiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"issue":"2","key":"1199_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.critrevonc.2012.12.009","volume":"87","author":"M Martelli","year":"2013","unstructured":"Martelli M, Ferreri AJ, Agostinelli C, Di Rocco A, Pfreundschuh M, Pileri SA. Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol 2013; 87(2): 146\u2013171","journal-title":"Crit Rev Oncol Hematol"},{"key":"1199_CR2","doi-asserted-by":"crossref","unstructured":"Liu QS, Harji F, Jones A, Tarnower AC. Type B lactic acidosis: a rare oncological emergency. BMJ Case Rep 2020; 13(3)","DOI":"10.1136\/bcr-2019-233068"},{"issue":"1","key":"1199_CR3","first-page":"252","volume":"149","author":"B Suetrong","year":"2016","unstructured":"Suetrong B, Walley KR. Lactic acidosis in sepsis: it\u2019s not all anaerobic: implications for diagnosis and management. Cestt 2016; 149(1): 252\u2013261","journal-title":"Cestt"},{"issue":"1","key":"1199_CR4","doi-asserted-by":"publisher","first-page":"6638","DOI":"10.1038\/s41467-023-42456-3","volume":"14","author":"S Jin","year":"2023","unstructured":"Jin S, Chen X, Yang J, Ding J. Lactate dehydrogenase D is a general dehydrogenase for D-2-hydroxyacids and is associated with D-lactic acidosis. Nat Commun 2023; 14(1): 6638","journal-title":"Nat Commun"},{"issue":"1","key":"1199_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gendis.2017.02.003","volume":"4","author":"B Jiang","year":"2017","unstructured":"Jiang B. Aerobic glycolysis and high level of lactate in cancer metabolism and microenvironment. Genes Dis 2017; 4(1): 25\u201327","journal-title":"Genes Dis"},{"issue":"6","key":"1199_CR6","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1113\/JP278810","volume":"599","author":"P Vaupel","year":"2021","unstructured":"Vaupel P, Multhoff G. Revisiting the Warburg effect: historical dogma versus current understanding. J Physiol 2021; 599(6): 1745\u20131757","journal-title":"J Physiol"},{"issue":"5","key":"1199_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1134\/S1990519X24700469","volume":"18","author":"VA Kobliakov","year":"2024","unstructured":"Kobliakov VA. Tumor tissue acidosis as a factor determining the malignant phenotype and tumor resistance to chemotherapy. Cell Tissue Biol 2024; 18(5): 489\u2013502","journal-title":"Cell Tissue Biol"},{"issue":"11","key":"1199_CR8","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.tips.2023.08.009","volume":"44","author":"S Borde","year":"2023","unstructured":"Borde S, Matosevic S. Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities. Trends Pharmacol Sci 2023; 44(11): 832\u2013848","journal-title":"Trends Pharmacol Sci"},{"key":"1199_CR9","doi-asserted-by":"publisher","first-page":"216837","DOI":"10.1016\/j.canlet.2024.216837","volume":"590","author":"S Chen","year":"2024","unstructured":"Chen S, Xu Y, Zhuo W, Zhang L. The emerging role of lactate in tumor microenvironment and its clinical relevance. Cancer Lett 2024; 590: 216837","journal-title":"Cancer Lett"},{"issue":"20","key":"1199_CR10","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1182\/blood-2017-08-800094","volume":"130","author":"GM Crane","year":"2017","unstructured":"Crane GM, Perkins AS. Leukemic presentation of diffuse large B-cell lymphoma: an unusual pattern associated with splenic involvement. Blood 2017; 130(20): 2233","journal-title":"Blood"},{"issue":"1","key":"1199_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.prp.2013.09.001","volume":"210","author":"E Wang","year":"2014","unstructured":"Wang E, Papavassiliou P, Wei Q, Wickham MQ, Cichon L, Proia AD. An Epstein-Barr virus-positive diffuse large B-cell lymphoma presenting as multi-organ failure: a catastrophic lymphomatosis with fulminant visceral organ dissemination resulting in a precipitous death in a 59-year-old female with no identifiable etiology for immunodeficiency. Pathol Res Pract 2014; 210(1): 62\u201366","journal-title":"Pathol Res Pract"},{"issue":"8","key":"1199_CR12","first-page":"e10110","volume":"12","author":"A Hafner","year":"2020","unstructured":"Hafner A, Eaton DB. Acute liver failure with severe lactic acidosis secondary to infiltrative diffuse large B-cell lymphoma: an imaging-negative presentation. Cureus 2020; 12(8): e10110","journal-title":"Cureus"},{"issue":"1","key":"1199_CR13","first-page":"e20927","volume":"14","author":"A Gkoufa","year":"2022","unstructured":"Gkoufa A, Georgakopoulou VE, Lakiotaki E, Cholongitas E. An unusual presentation of diffuse large B-cell lymphoma. Cureus 2022; 14(1): e20927","journal-title":"Cureus"},{"issue":"1","key":"1199_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4103\/0971-5851.133728","volume":"35","author":"A Kumar","year":"2014","unstructured":"Kumar A, Raina V. Non-Hodgkins lymphoma with lactic acidosis at presentation: a case report of a rare oncologic emergency. Indian J Med Paediatr Oncol 2014; 35(1): 83\u201385","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"2","key":"1199_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/MAJ.0b013e3181c3fdeb","volume":"339","author":"BC Keller","year":"2010","unstructured":"Keller BC, Nussensveig D, Dowell JE. Diffuse large B-cell lymphoma in a hepatitis C virus-infected patient presenting with lactic acidosis and hypoglycemia. Am J Med Sci 2010; 339(2): 202\u2013204","journal-title":"Am J Med Sci"},{"issue":"7","key":"1199_CR16","first-page":"e26557","volume":"14","author":"R Sanivarapu","year":"2022","unstructured":"Sanivarapu R, Upadrista PK, Otero-Colon J, Shah K, Cadet B, Tao Q, Iqbal J. An oncological emergency: severe type B lactic acidosis from Warburg effect in diffuse large B-cell lymphoma. Cureus 2022; 14(7): e26557","journal-title":"Cureus"},{"key":"1199_CR17","doi-asserted-by":"publisher","first-page":"e941270","DOI":"10.12659\/AJCR.941270","volume":"24","author":"P Weeraddana","year":"2023","unstructured":"Weeraddana P, Odujoko O, Bal S, Mannapperuma N, Maslak D, Gupta G. An elusive diagnosis: diffuse large B-Cell lymphoma masquerading as acute liver failure with persistent lactic acidosis. Am J Case Rep 2023; 24: e941270","journal-title":"Am J Case Rep"},{"issue":"10","key":"1199_CR18","doi-asserted-by":"publisher","first-page":"e230277","DOI":"10.1136\/bcr-2019-230277","volume":"12","author":"TJ Mohammed","year":"2019","unstructured":"Mohammed TJ, Gosain R, Sharma R, Torka P. Lactic acidosis: a unique presentation of diffuse large B-cell lymphoma. BMJ Case Rep 2019; 12(10): e230277","journal-title":"BMJ Case Rep"},{"issue":"2","key":"1199_CR19","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1159\/000509510","volume":"13","author":"T Hamada","year":"2020","unstructured":"Hamada T, Kaku T, Mitsu S, Morita Y, Ohno N, Yamaguchi H. Lactic acidosis and hypoglycemia in a patient with gastric diffuse large B-cell lymphoma due to the Warburg effect. Case Rep Oncol 2020; 13(2): 1047\u20131052","journal-title":"Case Rep Oncol"},{"issue":"2","key":"1199_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2478\/jccm-2019-0010","volume":"5","author":"Y He","year":"2019","unstructured":"He Y, Ong J, Ong S. Refractory lactic acidosis and an approach to its management\u2014a case report. J Crit Care Med (Targu Mures) 2019; 5(2): 60\u201365","journal-title":"J Crit Care Med (Targu Mures)"},{"issue":"5","key":"1199_CR21","first-page":"e2561","volume":"10","author":"H Arif","year":"2018","unstructured":"Arif H, Zahid S, Kaura A. Persistent lactic acidosis: thinking outside the box. Cureus 2018; 10(5): e2561","journal-title":"Cureus"},{"issue":"1","key":"1199_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/08998280.2017.11929534","volume":"30","author":"U Masood","year":"2017","unstructured":"Masood U, Sharma A, Nijjar S, Sitaraman K. B-cell lymphoma, thiamine deficiency, and lactic acidosis. Proc Bayl Univ Med Cent 2017; 30(1): 69\u201370","journal-title":"Proc Bayl Univ Med Cent"},{"issue":"12","key":"1199_CR23","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1210\/jc.2012-2327","volume":"97","author":"GC Elhomsy","year":"2012","unstructured":"Elhomsy GC, Eranki V, Albert SG, Fesler MJ, Parker SM, Michael AG, Griffing GT. \u201cHyper-warburgism,\u201d a cause of asymptomatic hypoglycemia with lactic acidosis in a patient with non-Hodgkin\u2019s lymphoma. J Clin Endocrinol Metab 2012; 97(12): 4311\u20134316","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1199_CR24","doi-asserted-by":"publisher","first-page":"e18968","DOI":"10.1016\/j.heliyon.2023.e18968","volume":"9","author":"D Yu","year":"2023","unstructured":"Yu D, Tang X, Xue H, Ao Y, Xie Y, Li X. Paraneoplastic syndrome in malignant lymphoma: a case report. Heliyon 2023; 9(8): e18968","journal-title":"Heliyon"},{"issue":"2","key":"1199_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1258\/acb.2012.012125","volume":"50","author":"D Hoogwerf","year":"2013","unstructured":"Hoogwerf D, van Doorn J, Maartense E. The insulin-like growth factor-system in a patient with diffuse large B-cell non-Hodgkin\u2019s lymphoma and lactic acidosis. Ann Clin Biochem 2013; 50(2): 169\u2013172","journal-title":"Ann Clin Biochem"},{"issue":"2","key":"1199_CR26","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1159\/000517658","volume":"14","author":"Z Al Maqrashi","year":"2021","unstructured":"Al Maqrashi Z, Sedarous M, Pandey A, Ross C, Wyne A. Refractory hyperlactatemia and hypoglycemia in an adult with non-Hodgkin\u2019s lymphoma: a case report and review of the Warburg effect. Case Rep Oncol 2021; 14(2): 1159\u20131167","journal-title":"Case Rep Oncol"},{"issue":"5","key":"1199_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/1545109710377803","volume":"9","author":"MH Kestler","year":"2010","unstructured":"Kestler MH, Gardner EM, Cohn DL. Hepatic non-Hodgkin\u2019s lymphoma with lactic acidosis in HIV-infected patients: report of 2 cases. J Int Assoc Physicians AIDS Care (Chic) 2010; 9(5): 301\u2013305","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"1199_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.12659\/AJCR.889580","volume":"14","author":"G Tanios","year":"2013","unstructured":"Tanios G, Aranguren IM, Goldstein JS, Patel CB. Diffuse large B-cell lymphoma: a metabolic disorder? Am J Case Rep 2013; 14: 518\u2013525","journal-title":"Am J Case Rep"},{"issue":"1","key":"1199_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13613-023-01192-z","volume":"13","author":"A Chaba","year":"2023","unstructured":"Chaba A, Fodil S, Lemiale V, Mariotte E, Valade S, Azoulay E, Zafrani L. Clinical Warburg effect in lymphoma patients admitted to intensive care unit. Ann Intensive Care 2023; 13(1): 97","journal-title":"Ann Intensive Care"},{"issue":"3","key":"1199_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1053\/j.ajkd.2013.03.036","volume":"62","author":"P Sia","year":"2013","unstructured":"Sia P, Plumb TJ, Fillaus JA. Type B lactic acidosis associated with multiple myeloma. Am J Kidney Dis 2013; 62(3): 633\u2013637","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1199_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/diagnostics12020394","volume":"12","author":"A Alfaifi","year":"2022","unstructured":"Alfaifi A, Bahashwan S, Alsaadi M, Malhan H, Aqeel A, Al-Kahiry W, Almehdar H, Qadri I. Metabolic biomarkers in B-cell lymphomas for early diagnosis and prediction, as well as their influence on prognosis and treatment. Diagnostics (Basel) 2022; 12(2): 394","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"1199_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/hon.2752","volume":"38","author":"Y Cao","year":"2020","unstructured":"Cao Y, Chen P, Cai M, Shi Q, Xu P, Wang L, He Y, Wang H, Zhao W. Prognostic impact of B-vitamins involved in one-carbon metabolism in patients with diffuse large B-cell lymphoma. Hematol Oncol 2020; 38(4): 456\u2013466","journal-title":"Hematol Oncol"},{"key":"1199_CR33","doi-asserted-by":"publisher","first-page":"1003588","DOI":"10.3389\/fonc.2022.1003588","volume":"12","author":"R Hamaguchi","year":"2022","unstructured":"Hamaguchi R, Isowa M, Narui R, Morikawa H, Wada H. Clinical review of alkalization therapy in cancer treatment. Front Oncol 2022; 12: 1003588","journal-title":"Front Oncol"},{"issue":"3","key":"1199_CR34","first-page":"258","volume":"66","author":"ML Halperin","year":"1994","unstructured":"Halperin ML, Cheema-Dhadli S, Halperin FA, Kamel KS. Rationale for the use of sodium bicarbonate in a patient with lactic acidosis due to a poor cardiac output. Nephron J 1994; 66(3): 258\u2013261","journal-title":"Nephron J"},{"issue":"11","key":"1199_CR35","first-page":"100408","volume":"3","author":"S Piha-Paul","year":"2022","unstructured":"Piha-Paul S, Simon G, Belani CP, Chao H, Gaspar K, Lee B, Dowlati A. A phase 1, open-label, dose-escalation study of L-DOS47 in combination with pemetrexed plus carboplatin in patients with stage IV recurrent or metastatic nonsquamous NSCLC. JTO Clin Res Rep 2022; 3(11): 100408","journal-title":"JTO Clin Res Rep"},{"issue":"10196","key":"1199_CR36","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S0140-6736(19)31388-1","volume":"394","author":"DE Wesson","year":"2019","unstructured":"Wesson DE, Mathur V, Tangri N, Stasiv Y, Parsell D, Li E, Klaerner G, Bushinsky DA. Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension. Lancet 2019; 394(10196): 396\u2013406","journal-title":"Lancet"},{"issue":"10","key":"1199_CR37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrneph.2012.186","volume":"8","author":"JA Kraut","year":"2012","unstructured":"Kraut JA, Madias NE. Treatment of acute metabolic acidosis: a pathophysiologic approach. Nat Rev Nephrol 2012; 8(10): 589\u2013601","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"1199_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1440-1681.2009.05296.x","volume":"37","author":"D Wu","year":"2010","unstructured":"Wu D, Qi J, Dai H, Doods H, Abraham WM. Resuscitation with Na+\/H+ exchanger inhibitor in traumatic haemorrhagic shock: cardiopulmonary performance, oxygen transport and tissue inflammation. Clin Exp Pharmacol Physiol 2010; 37(3): 337\u2013342","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"1199_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/01.CCM.0000198107.61493.5A","volume":"34","author":"D De Backer","year":"2006","unstructured":"De Backer D, Creteur J, Dubois MJ, Sakr Y, Koch M, Verdant C, Vincent JL. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006; 34(2): 403\u2013408","journal-title":"Crit Care Med"},{"issue":"12","key":"1199_CR40","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.3390\/ph15121496","volume":"15","author":"C Zanza","year":"2022","unstructured":"Zanza C, Facelli V, Romenskaya T, Bottinelli M, Caputo G, Piccioni A, Franceschi F, Saviano A, Ojetti V, Savioli G, Longhitano Y. Lactic acidosis related to pharmacotherapy and human diseases. Pharmaceuticals (Basel) 2022; 15(12): 1496","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["MedScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-025-1199-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11684-025-1199-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-025-1199-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:12:22Z","timestamp":1778127142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11684-025-1199-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1199"],"URL":"https:\/\/doi.org\/10.1007\/s11684-025-1199-2","relation":{},"ISSN":["3091-4973","3091-4981"],"issn-type":[{"value":"3091-4973","type":"print"},{"value":"3091-4981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Conflicts of Interest\n                      Yu Jiao, Jingwen Zhang, Xiaojing Yan, and Na Lin declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital of China Medical University and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all patients for being included in the study. Additional informed consent was obtained from all patients whose identifying information is included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}